Analyst Ratings for AbbVie Inc. (ABBV)

Updated: 2017-07-28

Analysts covering AbbVie Inc. (NYSE:ABBV) have given it a consensus rating of Overweight. Last month, ABBV received an average rating of Overweight.

A buy rating was issued by 8 analysts, 2 issued an overweight rating, 12 gave a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Many analysts weighed in on price targets for ABBV. The highest price target was 95, implying a possible profit of 32.44 percent. The minimum price target given was 60, implying potential capital losses of -16.35 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. That number becomes 1.82 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 0.46 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, while 2 analysts revised their estimates downwards. Over the same time period, 2 analysts revised their FY earnings estimates upwards, while 2 analysts made negative revisions to their fiscal year's estimates.

ABBV has an estimated earnings growth rate of 41.4 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. People often look for the PEG ratio to be under 1, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of ABBV is 0.45.

In the last 52-weeks, ABBV has achieved a high of 75.04 and a low of 55.06. Today's price is 30.28 percent above the 52-week low, and below the high by 4.41 percent. ABBV has a P/E ratio of 18.58. Investors typically compare the P/E ratio to a company's peers in the industry. The ABBV value stock report compares ABBV to some of its peers using value stock charts. The stock has a market capitalization of $115.53 billion. ABBV will post this quarters earnings in days, on 0000-00-00.